Literature DB >> 12016125

Characterization of CCK(A) receptor affinity states and Ca(2+) signal transduction in vagal nodose ganglia.

Tim O Lankisch1, Yasuhiro Tsunoda, Yuanxu Lu, Chung Owyang.   

Abstract

CCK(A) receptors are present on vagal afferent fibers. The objectives of this study were to identify the presence of high- and low-affinity CCK(A) receptors on nodose ganglia and to characterize the intracellular calcium signal transduction activated by CCK. Stimulation of acutely isolated nodose ganglion cells from rats with 1 nM CCK-8 primarily evoked a Ca(2+) transient followed by a sustained Ca(2+) plateau (45% of cells responded), whereas 10 pM CCK-8 evoked Ca(2+) oscillations (37% of cells responded). CCK-OPE, a high-affinity agonist and low-affinity antagonist of CCK(A) receptors, primarily elicited Ca(2+) oscillations (29% of cells responded). CCK-OPE inhibited the Ca(2+) transient induced by 1 nM CCK-8 but not by carbachol and high K(+). This result suggests the presence of high- and low-affinity states of CCK(A) receptors on nodose ganglia. We further demonstrated that nicardipine (10 microM) but not omega-conotoxins GVIA and MVIIC (10-100 nM) abolished Ca(2+) signaling induced by CCK-8, indicating that an L-type voltage-dependent Ca(2+) channel and not an N- or Q-type Ca(2+) channel is coupled to CCK(A) receptors. In a separate study, we showed that the G protein activator NaF (10 mM) elicited a Ca(2+) transient and inhibited CCK-8-evoked Ca(2+) signaling, indicative of G protein(s) involvement in CCK(A) receptor activity. The G(q) protein antagonist Gp antagonist-2A (10 microM) also abolished the action of CCK-8. This study indicates that CCK(A) receptors exist in both high- and low-affinity states in the nodose ganglia. Activation of high-affinity CCK(A) receptors elicits Ca(2+) oscillations, whereas stimulation of low-affinity CCK(A) receptors evokes a sustained Ca(2+) plateau. These Ca(2+)-signaling modes are mediated through the L-type Ca(2+) channel and involve the participation of G(q) protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016125     DOI: 10.1152/ajpgi.00313.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  12 in total

1.  Contributing mechanisms underlying desensitization of cholecystokinin-induced activation of primary nodose ganglia neurons.

Authors:  Cody W Kowalski; Jonathan E M Lindberg; Daniel K Fowler; Steven M Simasko; James H Peters
Journal:  Am J Physiol Cell Physiol       Date:  2020-02-19       Impact factor: 4.249

2.  Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse.

Authors:  Donna M Daly; Sung Jin Park; William C Valinsky; Michael J Beyak
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

3.  TMEM16B determines cholecystokinin sensitivity of intestinal vagal afferents of nodose neurons.

Authors:  Runping Wang; Yongjun Lu; Michael Z Cicha; Madhu V Singh; Christopher J Benson; Christopher J Madden; Mark W Chapleau; François M Abboud
Journal:  JCI Insight       Date:  2019-03-07

4.  Pharmacological investigations of the cellular transduction pathways used by cholecystokinin to activate nodose neurons.

Authors:  Huan Zhao; Dallas C Kinch; Steven M Simasko
Journal:  Auton Neurosci       Date:  2011-06-12       Impact factor: 3.145

5.  Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Authors:  J Kong; J Chuddy; I A Stock; P M Loria; S V Straub; C Vage; K O Cameron; S K Bhattacharya; K Lapham; K F McClure; Y Zhang; V M Jackson
Journal:  Br J Pharmacol       Date:  2016-03-17       Impact factor: 8.739

6.  Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons.

Authors:  Huan Zhao; Steven M Simasko
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

7.  Vagal afferent NMDA receptors modulate CCK-induced reduction of food intake through synapsin I phosphorylation in adult male rats.

Authors:  Carlos A Campos; Hiroko Shiina; Michael Silvas; Stephen Page; Robert C Ritter
Journal:  Endocrinology       Date:  2013-05-28       Impact factor: 4.736

8.  Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones.

Authors:  Y Li; X Y Wu; C Owyang
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

9.  Mechanisms of action of CCK to activate central vagal afferent terminals.

Authors:  Richard C Rogers; Gerlinda E Hermann
Journal:  Peptides       Date:  2008-07-04       Impact factor: 3.750

10.  Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Authors:  Di Wen; Chun-Ling Ma; Ya-Jing Zhang; Yan-Xin Meng; Zhi-Yu Ni; Shu-Jin Li; Bin Cong
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.